65 results
8-K
EX-99.1
CDTX
Cidara Therapeutics Inc
15 May 24
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:22pm
it is indicative of the significant potential of CD388 as a universal preventative of seasonal and pandemic influenza. We believe that CD388 may have
8-K
EX-99.1
CDTX
Cidara Therapeutics Inc
3 May 24
Other Events
8:00am
safety, efficacy and PK objectives Coverage of diverse panels of seasonal and pandemic strains1 Single SQ or IM dose per flu season Streamlined, low … n i v e r s a l ” p r e v e n t i o n a n d t r e a t m e n t Potent in-vitro and in-vivo activity against all tested seasonal and pandemic strains
8-K/A
EX-2.1
bjqc x5jrjc0d
29 Apr 24
Entry into a Material Definitive Agreement
4:57pm
8-K
EX-99.1
oiakkqybt61gr99cpt1i
6 Sep 23
Cidara Therapeutics Announces Janssen’s Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza
8:05am
8-K
EX-99.1
8xe6tu1l
11 May 23
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
myy4z5 gcmedy
3 Nov 22
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
5:30pm
PRE 14A
gx92vw fwx2d
31 Oct 22
Preliminary proxy
5:28pm
8-K
EX-99.1
0one3 dxm32pi4y0
11 May 22
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:08pm
8-K
EX-99.1
ob4jmc
7 Mar 22
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
5:15pm